Clifford Chance has deep knowledge and extensive experience in advising companies experiencing a dawn raid
conducted by regulatory authorities in Europe, Asia and the United States.
Not exact matches
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted
by the FDA in different ways than we interpret it; the FDA may not agree with our
regulatory approval strategies or components of our filings for our products, including our clinical trial designs,
conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials;
regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or
regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization
by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made
by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
We do this
by conducting clinical trials in which we collect safety and efficacy data about our experimental drugs with the goal of submitting those data to
regulatory authorities, like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), so that these experimental drugs can be approved for use
by patients.
In addition, all Golden Rice field trials in the Philippines are
conducted under permits issued
by the Bureau of Plant Industry of the Department of Agriculture (DA - BPI), the national
regulatory authority in the Philippines for crop biotechnology R&D, after they established that the trials will pose no significant risks to human health and the environment.
Stakeholder consultations were
conducted within jurisdictions using the arrangements determined
by jurisdictional
authorities, major employing
authorities and teacher
regulatory authorities.
Developing, issuing and enforcing safety regulations are a significant portion of PHMSA's work; however, PHMSA also
conducts research, funds State
regulatory authorities, emergency responders, and representatives of communities affected
by hazardous materials transportation, and educates stakeholder groups — including the general public — through outreach initiatives and training.
What's more, Wizzcash is regulated
by the Financial
Conduct Authority, the
regulatory body that is responsible for the
conduct of the financial services industry.
Our teams of specialist criminal defence lawyers represent corporate and individual clients throughout
regulatory and criminal investigations
conducted by The Financial Services
Authority (FSA) enforcement division.
Our lawyers have acted for architects, engineers, lawyers, dentists, and accountants in professional errors and omissions claims, advised clients before professional
regulatory bodies, acted for professional administrative bodies, provided advice regarding investigations
conducted by administrative
authorities, and have acted in judicial reviews of decisions made
by professional
regulatory bodies.
It shrinks the broad, unfettered discretion [the prior framework gave] the relevant
regulatory authorities to
conduct a compliance audit of an ILP, albeit only of an ILP, to a discretion which is properly exercised only in response to
conduct which has or is alleged to have occurred in the past — and
conduct which inevitably comes to attention only haphazardly, in ways which underreport
conduct which ought attract
regulatory scrutiny
by many tens, if not hundreds of times.
Recent work includes the defence of a large financial institution in connection with the LIBOR and FX investigations
conducted by the Criminal and Antitrust Divisions of the DOJ, the CFTC, the SEC, the FCA and a range of other international criminal, competition and
regulatory authorities across Europe.
Clifford Chance's Dawn Raids App is the first to offer advice on handling of raids
conducted by over 80
regulatory authorities globally, such as, for example, raids
conducted by judiciary and administrative
authorities, including competition, tax and market
authorities and more.
She advises clients on a wide range of privacy - compliance initiatives, including
conducting privacy and security reviews and audits; drafting privacy policies, practices and procedures; managing privacy / security breaches; assisting with investigations
by privacy
regulatory authorities; and drafting outsourcing and other service - provider agreements involving transfers (including transborder flows) of personal information.